Prasinezumab

Latest Posts

PADOVA examine confirmed numerical delay in motor development and constructive developments on a number...

Market

Roche’s Part IIb Examine of Prasinezumab Missed Major Endpoint, However Suggests Doable Medical Profit in Early-Stage Parkinson’s Illness By Investing.com